A reason why measures to avoid mite-induced asthma are more effective in children than in adults

A B Murray1, B J Morrison

  • 1Department of Pediatrics, B.C.'s Children's Hospital, Vancouver, Canada.

Insights

Children with mite-sensitive asthma show greater improvement with reduced mite allergen exposure in bedding compared to adults. This is likely due to children spending significantly more time in bed, increasing allergen exposure.

Area of Science:

  • Allergy and Immunology
  • Pediatric Respiratory Medicine
  • Environmental Health

Background:

  • Mite-sensitive asthma is a common condition, particularly in children.
  • Previous observations suggest children with asthma respond better to allergen avoidance in bedrooms than adults.
  • The specific reasons for this differential response require further investigation.

Purpose of the Study:

  • To investigate the difference in mite allergen exposure between children and adults with mite-sensitive asthma.
  • To explore the relationship between time spent in bed and allergen exposure in pediatric asthma patients.

Main Methods:

  • A study of 882 children attending an allergy clinic was conducted.
  • Standardized questionnaires were administered to parents.
  • Skin prick tests for Dermatophagoides pteronyssinus and D. farinae were performed on children.
  • Time spent in bed was recorded and analyzed based on age.

Main Results:

  • Children spent a mean of 12.0 hours in bed daily, significantly longer than their parents (8.4 hours).
  • Time spent in bed decreased with increasing age in children.
  • Skin prick tests confirmed mite sensitivity in the pediatric population.

Conclusions:

  • Children with mite-sensitive asthma experience longer daily exposure to mite allergens in bed compared to adults.
  • This prolonged exposure is a likely factor contributing to the more pronounced response observed in children to allergen avoidance measures in the bedroom.

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...